Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Accepted for publication April 5, 2022
- Published online July 28, 2022.
Article Versions
- Latest version (April 15, 2022 - 04:00).
- Latest version (June 1, 2022 - 04:00).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2022 by the Journal of Rheumatology This is an Open Access article, which permits use, distribution, and reproduction, without modification, provided the original article is correctly cited and is not used for commercial purposes.
Author Information
- Tien Nguyen1,
- Melvin Churchill2,
- Robert Levin3,
- Guillermo Valenzuela4,
- Joseph F. Merola5,
- Alexis Ogdie6,
- Ana-Maria Orbai7,
- Jose U. Scher8,
- Arthur Kavanaugh9,
- Farid Kianifard10,
- Chauncy Rollins10,
- Renato Calheiros10 and
- Olivier Chambenoit10
- 1T. Nguyen, MD, First OC Dermatology, Irvine, California;
- 2M. Churchill, MD, Arthritis Center of Nebraska, Lincoln, Nebraska;
- 3R. Levin, MD, Clinical Research of West Florida, Inc., Clearwater, Florida, and University of South Florida, Tampa, Florida;
- 4G. Valenzuela, MD, Integral Rheumatology & Immunology Specialists, Plantation, Florida, USA;
- 5J.F. Merola, MD, Department of Dermatology and Medicine, Division of Rheumatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts;
- 6A. Ogdie, MD, MSCE, Department of Medicine/Rheumatology and Department of Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania;
- 7A.M. Orbai, MD, MHS, Division of Rheumatology, Psoriatic Arthritis Program, Johns Hopkins University School of Medicine, Baltimore, Maryland;
- 8J.U. Scher, MD, Division of Rheumatology, New York University School of Medicine and NYU Langone Orthopedic Hospital, New York, New York;
- 9A. Kavanaugh, MD, Division of Rheumatology, Allergy and Immunology, Department of Medicine, University of California, San Diego, La Jolla, California;
- 10F. Kianifard, PhD, C. Rollins, MS, R. Calheiros, MD, O. Chambenoit, PhD, Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
- Address correspondence to Dr. T.Q. Nguyen, First OC Dermatology, 17305 Von Karman Avenue, Suite 107, Irvine, CA 92614, USA. Email: tiennguyenmd82{at}gmail.com.
